← All markets

China

3,813.79-3.1%

The world's second-largest economy, with thousands of companies listed in Shanghai and Shenzhen. Strong in banking, manufacturing, consumer brands and fast-growing tech, though heavily shaped by government policy.

Index ·

Why is China moving?

Latest
▲1▼1

AI revenue reality check hits China tech; EU hybrid deal, fiberglass boom

  • OpenAI revenue miss triggers A-share AI hardware selloff OpenAI's annualized revenue came in about $20 billion below expectations, sparking a global tech selloff. China's STAR 50 fell nearly 4%, with AI hardware names like Fenghua Advanced and Zhongji Innolight dropping sharply. The panic reflects fears that AI infrastructure spending may not justify current valuations, pressuring chip, PCB and MLCC shares.

    This is the period's biggest force moving China's tech-heavy markets, directly hitting AI hardware stocks.

  • EU-China deal to halve Chinese hybrid exports The EU and China reached a preliminary deal to cut Chinese hybrid vehicle exports to Europe by more than half, easing pressure on Volkswagen, Stellantis and Renault. Chinese brands had nearly 12% of Europe's new-car market. The deal is a headwind for Chinese automakers' overseas growth, though details remain limited and BYD, XPeng and Zeekr still plan expanded European lineups.

    It directly affects the overseas growth engine of China's automakers, a key market driver.

  • China Jushi profit doubles on fiberglass demand China Jushi expects first-three-quarter net profit to double year-on-year to 5.1-5.4 billion yuan, as demand in major downstream applications rose and both volumes and prices increased. The profit alert signals real end-market demand in construction, wind power and electronics, supporting materials and industrial shares.

    It shows genuine earnings growth in a key materials sector, a positive counterweight to tech weakness.

  • Kling AI plans Hong Kong IPO; Fortescue hit by CMRG restrictions Kuaishou's Kling AI selected underwriters for a Hong Kong IPO aiming to raise at least $1 billion, adding to the AI capital boom. Meanwhile, China's CMRG asked steel mills to avoid Fortescue's iron ore during supply talks, threatening seaborne demand and pressuring the miner's cash balance, which fell 37%.

    It captures both the ongoing AI capital-raising wave and China's use of procurement power in commodities.

News moving China
ChinaHong Kong SAR China
China

China Includes National Blockchain Network in Policy Document

The Central Committee of the Communist Party of China and the State Council on October 9 published a policy document titled "Opinions on Developing New Quality Productive Forces" aimed at raising industrial technology and productivity, explicitly setting out a plan to build a "national blockchain network" to link the real economy, including manufacturing, with the digital economy. The national blockchain network is to be developed alongside a nationwide integrated computing resource network and is positioned as one of the efforts to advance the building of national data infrastructure. The policy also covers applying research results to business, the digitalization of manufacturing, and the use of artificial intelligence, and includes a plan to clarify who holds rights over data and to put in place mechanisms for transactions, profit sharing, and the protection of rights. In China, blockchain infrastructure supporting trade and finance is already being developed, and seven departments including the Shanghai Municipal Commission of Commerce on August 10 indicated in a plan to expand services trade that they would further advance the development of a "National Blockchain Network Shanghai Hub." The Hong Kong Monetary Authority on March 2 also announced cooperation with institutions responsible for data administration in Shanghai and others on the digitalization of goods trade and finance. Meanwhile, eight institutions including the People's Bank of China on February 6 published a notice tightening regulation of crypto assets, strictly prohibiting businesses that exchange crypto assets on the mainland and the issuance of tokens to raise funds.
NADA NEWS·1hRead more →
United StatesChinaCanadaIndonesia
China▼

Meta Blocks TikTok Ads in Seven Countries as China Halts Manus AI Deal

Meta Platforms has halted ByteDance's TikTok advertising on Facebook and Instagram across several major markets as of early October 2026, cutting off the rival from using its apps as paid funnels to its short form video service in seven countries including the US, Canada and Indonesia. The move removes TikTok's paid promotion inventory from Meta's core social apps in multiple countries where both groups compete for users, reducing TikTok's ability to pay for user acquisition inside Meta's ecosystem and keeping more ad slots available for consumer brands and other advertisers. Separately, Chinese authorities have blocked Meta's attempt to acquire AI startup Manus, prompting Meta to abandon the transaction and cut ties with the target. Both developments underline heavier regulatory friction and uncertainty around AI investments already flagged as a risk in Meta's narrative, showing how cross border rules can limit access to AI talent and assets just as the firm spends heavily on multi gigawatt compute clusters and Muse related products. Attention now turns to how quickly Meta Enterprise Platform and Muse agents gain paying business users through 2027, with disclosed figures on active enterprise customers, usage of Muse APIs or new country rollouts serving as key proof points.
About megatrends
Artificial Intelligence › AI Applications & Copilots Competition
Artificial Intelligence › Agentic AI & Autonomous Workflows Competition
META · Competition · Negative Meta halts TikTok's paid advertising on Facebook and Instagram in seven countries, cutting off a rival's user-acquisition funnel.
META · Regulation · Negative Chinese authorities blocked Meta's acquisition of AI startup Manus, forcing Meta to abandon the deal and cut ties.
ByteDance · Competition · Negative TikTok loses paid promotion inventory on Meta's apps in seven countries, reducing its ability to pay for user acquisition.
Read original ↗
Yahoo Finance·5hRead more →
ChinaUnited States
China▲

Baili Tianheng's Yizekang Combined with Radiotherapy for Head and Neck Squamous Cell Carcinoma Receives Clinical Trial Approval

Baili Tianheng announced that the company recently received a Drug Clinical Trial Approval Notice issued by the National Medical Products Administration. The clinical trial of its self-developed, world-first bispecific antibody drug conjugate Yizekang, also known as luncoitab, in combination with radiotherapy for locally advanced unresectable head and neck squamous cell carcinoma and other solid tumors has been approved. To date, the drug has initiated more than 45 clinical trials in China and the United States, including 20 Phase III clinical studies, and 9 indications have been included in the breakthrough therapy designation list by the Center for Drug Evaluation.
About megatrends
Biotech & Genomic Medicine › Oncology Therapeutics ▲Regulation
Biotech & Genomic Medicine › Antibody-Drug Conjugates (ADC) ▲Regulation
Biotech & Genomic Medicine › Immuno-Oncology / Checkpoint ▲Regulation
688506.CG · Regulation · Positive Baili Tianheng received NMPA clinical trial approval for Yizekang combined with radiotherapy in head and neck squamous cell carcinoma.
Read original ↗
科创板日报·8hRead more →
China
China▼

Brokerage commission rates keep sliding, new-account rates fall below one ten-thousandth

An analysis of securities firms' operations in the first half of 2026 recently issued by the Securities Association of China shows that 150 securities firms achieved operating revenue of 329.81 billion yuan and net profit of 138.664 billion yuan, up 31.38% and 23.50% year on year respectively, with 136 firms profitable and 14 loss-making. Revenue from securities brokerage business reached 117.6 billion yuan, up 53.90% year on year, surpassing proprietary trading revenue of 113.097 billion yuan to regain its position as the industry's largest revenue source, but the high growth was mainly driven by average daily A-share turnover of 2.74 trillion yuan, up 96.90% year on year. Over the same period, the industry-wide average net commission rate for agency trading of securities fell to 0.0171%. Competition for new accounts is particularly intense. Datong Securities offered a VIP commission rate of 0.00691% for Shanghai and Shenzhen stocks in its official livestream, while Guosen Securities and Zhongtai Securities quoted all-in rates for new accounts of 0.00841% and 0.0085% respectively, and many institutions have already cut new-account rates below 0.01%. Xu Kang, chief financial industry analyst at Huachuang Securities, estimates that actual net rates on the institutional side mostly range from 0.015% to 0.02%, while nominal net commission rates for ordinary retail clients mostly remain around 0.025%. A person in charge of a securities firm branch told Jiemian News that once taxes, fees and operating costs are included, attracting customers at rates persistently below cost is not sustainable. To cope with the price war, institutions such as Guolian Minsheng Securities are pushing to transform traditional brokerage business into comprehensive wealth management. In the first half, 42 A-share listed securities firms recorded net fee income from brokerage business of 97.843 billion yuan, up 54.2% year on year, of which income from distribution of financial products was 10.287 billion yuan, up 84.75% year on year.
002736.CS · Pricing · Negative Guosen Securities quoted an all-in new-account commission rate of 0.00841%, reflecting the intensifying price war that erodes brokerage revenue
600918.CG · Pricing · Negative Zhongtai Securities quoted an all-in new-account commission rate of 0.0085%, part of the industry price war pushing rates below cost
大同证券 · Pricing · Negative Datong Securities offered a VIP commission rate of 0.00691% for Shanghai and Shenzhen stocks, the lowest cited in the new-account price war
601456.CG · Competition · Neutral Guolian Minsheng Securities is cited pushing to transform traditional brokerage into comprehensive wealth management to cope with the commission price war
Read original ↗
Jiemian·8hRead more →
European UnionFranceGermanyUnited KingdomChina
China▲

Avolon Places Firm Order for 110 Airbus Jets

Avolon has announced a firm order for 110 Airbus jets, comprising 75 A320neo family aircraft and 35 A330-900s, with options for a further 100 aircraft pending Bohai Leasing shareholder approval. The commitment from the leading lessor reinforces long-term demand visibility for Airbus's single-aisle and widebody programmes and deepens its presence in the leasing market. The order, once Bohai Leasing approves it, supports the long-term demand story but does not materially change the most immediate swing factors, which remain engine and supply chain reliability on the A320 family and the impact of elevated investment and Spirit AeroSystems integration costs on near-term free cash flow. Alongside the Avolon deal, Airbus Defence and Space has completed the first 32 new OneWeb satellites for Eutelsat, underlining the push to build a more meaningful second profit pillar outside commercial jets. Airbus's narrative projects 107.5 billion euros in revenue and 9.3 billion euros in earnings by 2029, requiring 11.8% yearly revenue growth and about a 3.4 billion euro earnings increase from 5.9 billion euros today, while some of the most optimistic analysts were already pencilling in about 122.6 billion euros of revenue and 10.4 billion euros of earnings by 2029.
About megatrends
Aerospace & Aviation › Airframe OEMs ▲Demand
AIR.PA · Demand · Positive Avolon placed a firm order for 110 Airbus jets (75 A320neo, 35 A330-900) with options for 100 more, reinforcing long-term demand visibility
Avolon Holdings Limited · Demand · Positive Avolon announced a firm order for 110 Airbus jets with options for a further 100, expanding its fleet
000415.CS · Demand · Positive Bohai Leasing shareholder approval is pending for Avolon's firm order of 110 Airbus jets, deepening its lessor presence
ETL.PA · Technology · Positive Airbus Defence and Space completed the first 32 new OneWeb satellites for Eutelsat
Read original ↗
Simply Wall St·14hRead more →
ChinaUnited States
China

Tesla China-Made EV Sales Rise 5% in September, Extending Growth Streak to 11 Months

Tesla delivered 95,366 China-made electric vehicles in September, a 5% increase from 90,812 vehicles a year earlier that extended its year-over-year growth streak to 11 consecutive months. The Shanghai factory shipped Model 3 and Model Y vehicles to China, Europe, Asia-Pacific and Canada during the month, according to Reuters, citing the China Passenger Car Association. Third-quarter deliveries from Shanghai rose 13.7%, even as Tesla's worldwide deliveries fell 2.1% from the record-setting quarter last year. To support demand in China, Tesla is offering promotions through October, with selected Model Y versions qualifying for a 7,000-yuan reduction on final payments and every Model 3 variant receiving 5,000 yuan off. The gains come amid intensifying competition in China, where Tesla's retail sales fell 12.4% year-over-year in August to 50,047 units, its weakest August since 2022, leaving it ranked fifth behind market leader BYD with 233,943 units.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) Demand
Electrification & Mobility › Western / Legacy & Pure-play OEMs Demand
TSLA · Demand · Positive Tesla's China-made EV deliveries rose 5% in September, extending its year-over-year growth streak to 11 months.
002594.CS · Competition · Neutral BYD is cited as China's market leader with 233,943 units, ahead of Tesla, but no new BYD-specific development is reported.
Read original ↗
Yahoo Finance·14hRead more →
ChinaUnited States
China

China September Passenger Vehicle Retail Sales Fall 24% Year on Year

China's passenger vehicle retail sales totaled roughly 1.7M in September, a 24% decline from a year ago, according to preliminary data released by the China Passenger Car Association on Saturday. Year-to-date retail sales fell 21% year on year to about 13.4M, though the broader passenger vehicle market expanded from August, with retail sales climbing roughly 10% from a month ago on the strength of new energy vehicles. Retail sales of passenger NEVs stood at about 1.1M in September, down roughly 12% year on year but accounting for about 67% of total passenger vehicle retail sales for the month. Year-to-date retail NEV sales totaled about 7.8M, down 12% year on year, while wholesale passenger NEV sales reached about 11.4M year to date, up 10% from a year ago, as the CPCA said higher oil prices stayed elevated longer than expected and fueled exports. The local market also faced tough comparisons from a year earlier, when sales climbed on a rush to buy new vehicles before some Chinese regions reined in trade-in subsidies. BYD, Geely Auto, Chery, Leapmotor and Tesla were among the top 10 manufacturers in the passenger NEV wholesale market last month, while XPeng, Li Auto and Nio ranked outside the top ten.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) Demand
Electrification & Mobility › China NEV Leaders Demand
Read original ↗
Seeking Alpha·14hRead more →
European UnionChinaGermanyFranceSpain
Chinaimpact 4

EU and China Reach Preliminary Deal to Cut Chinese Hybrid Vehicle Exports

The European Union and China reached a preliminary agreement on Friday to cut Chinese hybrid vehicle exports to the bloc by more than half, offering relief to European automakers ahead of next week's Paris Motor Show. The deal could ease competitive pressure on Volkswagen, Stellantis and Renault, which are struggling with declining sales and growing competition from Chinese manufacturers, though details remain limited and Germany's VDA automotive association described it only as an initial positive signal. Chinese brands captured nearly 12% of Europe's new-car market in August, according to Dataforce, and EU imports of Chinese cars and light commercial vehicles surged almost 75% to nearly 770,000 units during January-August, with hybrids currently avoiding the additional EU tariffs imposed on Chinese-made battery-electric cars. European manufacturers face mounting financial pressure, as Mercedes-Benz reported an 8% decline in third-quarter car sales while Volkswagen recently lowered its profit outlook following a similar warning from BMW. The Paris Motor Show, running October 12-18, will highlight efforts to defend European market share through affordable electric vehicles and new partnerships, with Renault's Dacia brand showcasing its second-generation Spring electric car priced below €18,000 in France, Volkswagen presenting its ID. Tiguan alongside a strategy involving four smaller electric vehicles manufactured in Spain, and Stellantis displaying more than 60 vehicles across eight brands including a Citroën electric concept developed using technology from Chinese partner Leapmotor, while Chinese competitors BYD, XPeng and Zeekr will also showcase expanded lineups.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) Competition
Electrification & Mobility › Western / Legacy & Pure-play OEMs ▲Competition
Electrification & Mobility › China NEV Leaders ▼Competition
RNL.PA · Tariff · Positive EU-China preliminary deal to cut Chinese hybrid vehicle exports by more than half would ease competitive pressure on Renault, which is struggling with declining sales and Chinese competition.
RNO.PA · Tariff · Positive EU-China preliminary deal to cut Chinese hybrid vehicle exports by more than half would ease competitive pressure on Renault, which is struggling with declining sales and Chinese competition.
STLA · Tariff · Positive EU-China deal to cut Chinese hybrid exports by over half eases competitive pressure on Stellantis, which is also showcasing vehicles at the Paris show.
VOW.XETRA · Tariff · Positive The preliminary EU-China agreement to cut Chinese hybrid exports eases competitive pressure on Volkswagen, which is also presenting its ID. Tiguan and Spain-built EVs at the Paris show.
VOW3.XETRA · Tariff · Positive The preliminary EU-China agreement to cut Chinese hybrid exports eases competitive pressure on Volkswagen, which is also presenting its ID. Tiguan and Spain-built EVs at the Paris show.
BMW.XETRA · Tariff · Positive The EU-China deal to curb Chinese hybrid imports offers relief to European automakers, though BMW is only cited for its profit warning context.
Read original ↗
Investing.com·22hRead more →
ChinaHungaryGermany
China▲

Zoomlion Mining Machinery Business Grows Over 57% as International Revenue Hits RMB 15.535 Billion

Zoomlion Heavy Industry Science & Technology Co., Ltd. is expanding its mining machinery business and strengthening international operations, with its mining machinery business growing by more than 57.20% year on year in the first half of 2026. Company-wide international revenue rose 12.45% to RMB 15.535 billion, accounting for 57.25% of total revenue, an increase of 1.67 percentage points from a year earlier. The company said growth in South America, Europe, Southeast Asia, Africa and East Asia outpaced its overall international growth rate. Zoomlion's mining portfolio covers excavation, loading, haulage, crushing and screening, with flagship models including the ZE4000G, a 400-tonne mining excavator, and the ZTE520 hybrid electric-drive mining truck, with a rated payload of 300 tonnes. Wu Yuanfeng, deputy general manager of Zoomlion Mining Machinery, said pure-electric products can cut costs by more than 50% and hybrid models can improve profitability by 15% or more, while hybrid mining trucks can cut fuel consumption by up to 40% and 100-tonne-class battery-electric mining trucks have logged more than 8,000 hours of stable operation. As of June 30, 2026, Zoomlion operated more than 30 primary business hubs, over 530 secondary and tertiary outlets, and more than 300 spare parts warehouses worldwide, with its Hungarian aerial work platform factory beginning production and its German facility expanded into a multipurpose hub.
000157.CS · Demand · Positive Mining machinery business grew over 57% YoY and international revenue rose 12.45% to RMB 15.535 billion, with growth led by South America, Europe, Southeast Asia, Africa and East Asia.
Read original ↗
PR Newswire·23hRead more →
ChinaSouth KoreaTaiwanUnited States
China

China's CSI 300 Falls Nearly 6% as AI Rally Bypasses Mainland Stocks

China's stock market has missed the global artificial intelligence rally in 2026, with the CSI 300 index down nearly 6% this year while South Korea's Kospi and Taiwan's Weighted Index gained more than 65%, according to Yardeni Research. Yardeni attributed the underperformance to three factors: a Chinese economy weighed down by weak consumption, deflation, youth unemployment and a property downturn now in its fifth year; major Chinese equity benchmarks' lack of the AI hardware manufacturers that drive regional markets, since South Korea and Taiwan benefit from Samsung Electronics, SK Hynix and TSMC while China's strengths lie mainly in AI models and applications with domestic hardware companies trading outside major benchmarks; and regulatory uncertainty following Beijing's technology crackdowns, including its intervention in Alibaba affiliate Ant Group's planned listing. The firm also cited US-China tensions and potential American restrictions on advanced chip exports and investment, and noted the MSCI China index's forward price-to-earnings ratio has declined to 10.2 from 11.7 in mid-May. The weakness persists even after onshore-listed companies reported nearly 26% profit growth in the second quarter, their strongest quarterly increase in five years. Yardeni further warned that China's dependence on AI-related exports poses another risk, with Nomura estimating semiconductors, computers and related products account for roughly half of China's export growth, meaning a slowdown in global AI spending could hurt China's economy even though its broader stock market has missed the rally elsewhere in Asia.
Investing.com·1dRead more →
ChinaHong Kong SAR China
China▲

3SBio Signs MindRank AI Deal to Commercialize Oral GLP-1 Obesity Drug MDR-001

3SBio subsidiaries Zhejiang Sunshine Mandi and Zhejiang Wansheng have signed an agreement with MindRank AI to commercialize MDR-001, an oral GLP-1 candidate in Phase 3 obesity trials. The deal lands as 3SBio shares trade at HK$15.07, with a 1-year total shareholder return down 45.58 percent, a 30-day share price return down 6.69 percent and a year-to-date share price return down 38.69 percent, even as the 3-year total shareholder return is up more than 2x. On valuation, 3SBio trades at a P/E of 3.9x against a Hong Kong Biotechs industry average of 17.3x and a peer group average of 36.2x, with an estimated fair P/E of 8.2x. A discounted cash flow model puts 3SBio's estimated future cash flow value at HK$33.62 versus the current HK$15.07 share price. Recent declines in revenue and net income, combined with the weak 1-year return, could pressure sentiment if MDR-001 progress disappoints.
About megatrends
Biotech & Genomic Medicine › Metabolic, Diabetes & Obesity ▲Technology
Longevity & Life Extension › GLP-1 Healthspan Proxies Technology
1530.HK · Demand · Positive 3SBio subsidiaries signed a deal with MindRank AI to commercialize the Phase 3 oral GLP-1 obesity candidate MDR-001, expanding its obesity drug pipeline.
MindRank AI Ltd · Demand · Positive MindRank AI signed the agreement with 3SBio to commercialize its oral GLP-1 candidate MDR-001.
603010.CG · Demand · Positive Zhejiang Wansheng is named as a 3SBio subsidiary signing the agreement to commercialize MDR-001.
Zhejiang Sansheng Wandi Pharmaceutical · Demand · Positive Zhejiang Sunshine Mandi is named as a 3SBio subsidiary signing the agreement to commercialize MDR-001.
Read original ↗
Simply Wall St·1dRead more →
China
China

Akeso Doses First Patient in Phase III Perioperative Cadonilimab Colon Cancer Study

Akeso, Inc. announced that the first patient has been dosed in a Phase III clinical study evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoadjuvant/adjuvant perioperative treatment of resectable microsatellite instability-high or mismatch repair-deficient colon cancer. The trial, designated COMPASSION-40/AK104-313, marks a significant new indication for cadonilimab beyond gastric, lung, and cervical cancers, and is the 13th Phase III or registrational study of the therapy conducted globally. Colorectal cancer is among the malignancies with the highest incidence and mortality worldwide, and patients with MSI-H/dMMR colon cancer derive limited benefit from conventional perioperative chemotherapy, with pathological response rates of only approximately 7%. No immunotherapy has yet been approved anywhere for the perioperative treatment of localized MSI-H/dMMR colon cancer. Supporting evidence comes from a prior Phase II study of cadonilimab monotherapy as neoadjuvant treatment in MSI-H/dMMR colorectal cancer, where data presented at the 2024 ESMO Immuno-Oncology Congress showed a pathological complete response rate of 84.6% and a major pathological response rate of 100% among patients who proceeded to surgery, with a manageable safety profile.
About megatrends
Biotech & Genomic Medicine › Immuno-Oncology / Checkpoint ▲Technology
Biotech & Genomic Medicine › Oncology Therapeutics ▲Technology
9926.HK · Technology · Positive First patient dosed in Phase III trial of cadonilimab for perioperative MSI-H/dMMR colon cancer, a new indication with strong prior Phase II response data.
Read original ↗
PR Newswire·1dRead more →
CanadaChinaUnited States
China▲

Geely Auto to Begin Sales in Canada in 2027, Eyeing U.S. Market Entry

Chinese auto giant Geely Auto announced on the 9th that it will begin selling vehicles in Canada in 2027. Although Canada's market is smaller than that of the United States, Chinese manufacturers are showing interest in expanding their operations in Canada with an eye toward future entry into the U.S. market. The company did not disclose details such as the models it will sell in Canada or their price ranges, but said it is moving forward with establishing a local subsidiary and building a sales and service network. Geely Auto, a company under Zhejiang Geely Holding Group, operates brands including the mass-market Geely and the premium Zeekr, and is working to expand sales channels for electric and other electrified vehicles overseas, including in Europe.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) ▲Competition
Electrification & Mobility › China NEV Leaders ▲Competition
0175.HK · Demand · Positive Geely Auto will begin selling vehicles in Canada in 2027, expanding its overseas sales channels with a local subsidiary and sales/service network.
Zeekr · Demand · Positive Zeekr is named as one of Geely's brands being used to expand electrified-vehicle sales channels overseas, including the new Canada market push.
Read original ↗
Jiji Press·1dRead more →
China
China▼

International Industrial withholds 107 million yuan in estimated liabilities; third-quarter results may swing from profit to loss and private placement terminated

International Industrial announced on the evening of October 9 that its board of directors approved a proposal to withhold estimated liabilities. Based on a tax dispute, it calculated estimated liabilities of 107 million yuan as of September 30, 2026, which is expected to reduce the company's current-period profit by 107 million yuan. The company's net profit attributable to the parent for the first half of 2026 was 15.2598 million yuan, and this withholding amount is about seven times that net profit, which may cause its third-quarter 2026 results to swing from profit to loss. The tax dispute originated from a notice ordering correction within a prescribed period issued on June 17, 2025 by the Second Tax Office of the Urumqi High-tech Zone Taxation Bureau of the State Taxation Administration, which determined that the company's enjoyment of the Western Development corporate income tax preferential policy for 2022 was disputed, requiring it to pay back taxes of 66.7264 million yuan and a late payment penalty at 0.05 percent per day. The administrative lawsuit filed by the company was dismissed by the Tianshan District People's Court of Urumqi on August 31, 2026. On the same day, the company's board also approved the termination of the issuance of shares to specific investors and the withdrawal of application documents. This is the third version of a private placement plan that has failed to be implemented in the past four years. The 2025 version had a fundraising cap of 662 million yuan, to be fully subscribed by the controlling shareholder Xinjiang Rongneng. Financial data shows that as of June 30, 2026, the company achieved operating revenue of 922 million yuan, down 2.48 percent year on year, net profit attributable to the parent of 15.2598 million yuan, down 38.39 percent year on year, and net cash flow from operating activities of negative 265 million yuan, down 558.95 percent year on year.
000159.CS · Capital · Negative Board terminated the third private placement plan in four years, withdrawing the 662 million yuan fundraising from controlling shareholder Xinjiang Rongneng.
000159.CS · Regulation · Negative Tax dispute ruling upheld, forcing 107 million yuan in back taxes and penalties that may swing Q3 from profit to loss.
新疆融能投资发展有限公司 · Capital · Negative As the controlling shareholder committed to fully subscribe the 662 million yuan private placement, the termination cancels that planned investment.
Read original ↗
包括自有资金和自筹资金·1dRead more →
China
China▲

Leading brokerages collectively join third-party AI platforms, with GF Securities and Guotai Haitong spearheading the push

Brokerages are shifting from developing their own large models to collectively joining third-party AI platforms. In early September, Tencent's WorkBuddy open platform went live, and GF Securities became the first brokerage to enter the ecosystem zone, launching 12 self-developed skills and 9 expert capabilities in the first batch, describing its Buddy application zone as a digital flagship store within Tencent's AI ecosystem. In late September, six AI skills from China Securities' self-developed Dragonfly Skill went live on the WorkBuddy skills marketplace. On September 7, Alibaba's Qwen open platform launched more than ten financial intelligent agents, with four brokerage bots among the first to join: Guotai Haitong's Lingxi, Industrial Securities' intelligent investment assistant, Soochow Securities' Xiucai, and CICC Wealth Management. Moonshot AI's Kimi released a financial industry solution, with China Securities and CICC among those deploying or co-building it in their operations. Jiemian News found that brokerages joining third-party AI platforms have formed two clear paths: one is listing professional tools as skills on AI office workbenches such as Tencent WorkBuddy, and the other is joining general AI assistants such as Alibaba's Qwen as standalone bots for conversational services. Yang Ling, a securities industry analyst at Analysys Qianfan, pointed out that the primary purpose of brokerages' intensive integration is to expand new user touchpoints, and the real value lies in first building user awareness and then gradually guiding users to their own apps, investment advisory, and wealth management services. According to Analysys data, in June 2026, the combined visits of 17 mainstream desktop AI-native office agent platforms in China exceeded 60 million. Tencent Marketing disclosed on September 15 that in 2026 it has completed the full chain of account opening and customer acquisition with brokerages, with more than 40 traditional brokerage headquarters investing in customer acquisition during the year, and leading brokerages' budgets reaching the tens of millions of yuan level. In terms of self-developed investment, the 2025 annual reports show that Guotai Haitong Securities ranked first with information technology investment of 3.235 billion yuan, Huatai Securities at 2.679 billion yuan, and China Merchants Securities, China Securities, CICC, GF Securities, China Galaxy Securities, Guosen Securities, and Shenwan Hongyuan also above 1 billion yuan.
About megatrends
Artificial Intelligence › AI Applications & Copilots ▲Technology
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Technology
Digital Finance & Tokenization › Digital Wealth & Robo-Advisory Technology
000776.CS · Technology · Positive GF Securities became the first brokerage to enter Tencent's WorkBuddy ecosystem zone, launching 12 self-developed skills and 9 expert capabilities.
601066.CG · Technology · Positive China Securities' self-developed Dragonfly Skill went live on Tencent's WorkBuddy skills marketplace and it is deploying/co-building Moonshot AI's Kimi financial solution.
601211.CG · Technology · Positive Guotai Haitong's Lingxi bot was among the first four brokerage bots to join Alibaba's Qwen financial intelligent agents.
Moonshot AI (北京月之暗面科技有限公司) · Demand · Positive Moonshot AI's Kimi released a financial industry solution with brokerages including China Securities and CICC deploying or co-building it, gaining new enterprise customers.
601377.CG · Technology · Positive Industrial Securities' intelligent investment assistant was among the first brokerage bots to join Alibaba's Qwen financial intelligent agents.
601555.CG · Technology · Positive Soochow Securities' Xiucai bot was among the first brokerage bots to join Alibaba's Qwen financial intelligent agents.
Read original ↗
Jiemian·1dRead more →
China
China▼

Shengnuo Bio subsidiary and actual controller prosecuted for bid-rigging, with illegal gains of 10.9796 million yuan

Shengnuo Bio announced on the evening of October 9 that its wholly owned subsidiary Chengdu Shengnuo Biopharmaceutical Co., Ltd. and actual controller Wen Yongjun had received an indictment from the People's Procuratorate of Yuhuatai District, Nanjing, Jiangsu Province, on suspicion of bid-rigging, with illegal gains of 10.9796 million yuan. According to the announcement, Shengnuo Pharmaceutical is suspected of participating in bid-rigging for the drug octreotide acetate injection in the seventh national volume-based procurement program. Relevant personnel promised, and Shengnuo Pharmaceutical actually won the bid as the fifth-ranked bidder, with illegal gains of 10.9796 million yuan during the contract period. Shengnuo Pharmaceutical sold 7.5107 million units of the injection, with sales amounting to 117 million yuan. Wen Yongjun was released on bail pending trial by the Yuhuatai branch on December 18, 2024, on suspicion of bid-rigging, and was again released on bail pending trial by the Yuhuatai procuratorate on December 17, 2025. He is still performing his duties normally. The procuratorate holds that this case constitutes a joint crime and a unit crime, and that Wen Yongjun, as the directly responsible person in charge, is the principal offender. However, because he surrendered voluntarily and truthfully confessed his crimes, he is considered to have turned himself in and may be given a lighter punishment. The company has already made a provision for the illegal gains of 10.9796 million yuan as an estimated liability in its 2025 financial statements. Because the amount of the fine is not yet determined, it is expected to affect the net profit attributable to shareholders of the listed company for this year or future years.
688117.CG · Regulation · Negative Wholly owned subsidiary and actual controller indicted for bid-rigging in national procurement, with illegal gains of 10.9796 million yuan and potential fines affecting net profit.
成都圣诺生物制药有限公司 · Regulation · Negative The subsidiary itself is prosecuted for bid-rigging the octreotide acetate injection in the seventh national volume-based procurement, with 10.9796 million yuan in illegal gains.
Read original ↗
每日经济新闻·1dRead more →
China
China▲

C&D Inc. and UBTECH Robotics Sign Strategic Cooperation to Jointly Promote Large-Scale Deployment of Humanoid Robots

On October 9, C&D Inc. and Shenzhen UBTECH Robotics Corporation Limited signed a strategic cooperation agreement in Xiamen. UBTECH Robotics founder, chairman and CEO Zhou Jian, director and senior vice president Hao Baoyu, and C&D Inc. chairman Lin Mao, along with other leaders from both sides, attended and witnessed the signing. Under the agreement, the two parties will leverage C&D Inc.'s channel network, supply chain system and financial leasing capabilities, combined with UBTECH Robotics' full-stack self-developed humanoid robot technology and mature product portfolio, to jointly promote the large-scale deployment of intelligent robots in government exhibition halls, commercial complexes, industrial parks and other scenarios. The two sides also held in-depth exchanges on topics including intelligent robot market expansion, regional scenario implementation, after-sales operation and maintenance system development, industry-finance innovation cooperation, and overseas market coordination, and reached consensus on business linkage and joint development of an industrial ecosystem. The signing marks the entry of the two parties' cooperation into a phase of all-round, systematic and large-scale deep collaboration. In the future, they will integrate industrial, channel, and operation and maintenance resources to form a nationwide embodied intelligence commercial operation ecosystem.
About megatrends
Robotics & Physical AI › Humanoid Robots ▲Demand
600153.CG · Demand · Positive C&D Inc. signed a strategic cooperation with UBTECH Robotics to jointly promote large-scale deployment of humanoid robots using its channel network and supply chain, expanding its robotics business.
Read original ↗
每日经济新闻·1dRead more →
China
China▼

Laiyifen's first-half revenue falls 6.6% as losses widen; franchise share rises to 89% while gross margin declines

On October 9, Laiyifen held its 2026 interim results briefing, with Chairman Shi Yonglei, President Yu Ruifen and other senior executives attending to face investor questions. The interim report shows first-half revenue of 1.812 billion yuan, down 6.6% year on year; net loss attributable to the parent was 92.13 million yuan, widening 81.77% from a loss of 50.68 million yuan in the same period last year; net loss after deducting non-recurring items reached 110 million yuan, down 93.43% year on year; net cash flow from operating activities swung from a net inflow of 22.4 million yuan a year earlier to a net outflow of 82.98 million yuan, a year-on-year plunge of 470.54%. The company has now posted losses for two consecutive years, with a net loss attributable to the parent of 75.27 million yuan in 2024 and 161 million yuan in 2025. The channel structure has undergone a fundamental shift. As of June 30, 2026, the total number of stores was 2,968, a net increase of 150 from the end of 2025. Directly operated stores fell sharply from 1,044 to 318, a net reduction of 726 in the half year, while franchised stores rose from 1,774 to 2,650, lifting their share from 63% to 89%. In the first half, franchise wholesale revenue was 983 million yuan, up 36.1% year on year, with its share rising to 54.26% and becoming the largest revenue source, about 2.16 times the 455 million yuan from direct operations. However, the gross margin of the franchise business was only 11.71%, down 2.54 percentage points from 14.25% a year earlier, while the direct-operation gross margin remained above 40%. As a result, the company's overall gross margin fell to 23.66%, while selling expenses dropped 38.28% year on year over the same period. Shi Yonglei told investors that the company will optimise the profit model for individual franchise stores and deepen lean management, that the current share transfer at the shareholder level does not change corporate control, and that as of now there are no confirmed industrial synergy arrangements with Donghe Hengyi. To support the franchise system, the company relaxed its credit policy, with accounts receivable rising 51.40% year on year to 65.73 million yuan and long-term receivables surging 2,250.15% to 16.92 million yuan. Management said the financial assistance is a supporting measure during the transition period.
603777.CG · Capital · Negative First-half revenue fell 6.6% and net loss widened 81.77% to 92.13 million yuan, with operating cash flow swinging to a net outflow.
603777.CG · Pricing · Negative Franchise gross margin fell 2.54pp to 11.71%, dragging overall gross margin down to 23.66%.
Read original ↗
读创财经·1dRead more →
China
China

Changan Automobile confirms receiving brake pedal material survey from CATARC

Changan Automobile confirmed to Red Star Capital Bureau that on October 9 it received a survey questionnaire from CATARC regarding brake pedal assembly materials, with the questionnaire focusing on the application of non-metallic materials in pedal assemblies. CATARC is a central state-owned enterprise directly under the State-owned Assets Supervision and Administration Commission of the State Council, entrusted by the Ministry of Industry and Information Technology to conduct research on automotive standards and regulations. Industry insiders believe this survey may have been influenced by the incident involving the fracture of the brake pedal bracket on the Maextro V800, and could promote revisions to industry standards such as Performance Requirements and Bench Test Methods for Automotive Pedal Devices, with the questionnaire serving as preparatory work. Industry insiders pointed out that current national and industry standards lack quantitative load thresholds, material restrictions, or test methods for brake pedals and their brackets, leaving a standards gap for non-metallic brake pedal assemblies, and automakers may use non-metallic materials as long as they can demonstrate performance equivalent to metal materials. After the incident, executives from automakers including Voyah, Dongfeng Peugeot Citroën Automobile, Yangwang, and GAC Honda posted photos of their own brake pedals and emphasized the use of high-strength metal materials, while an industry insider close to JAC Motors said that brake pedal brackets on many models have long used non-metallic composite materials as part of lightweight design following the development of new energy vehicles.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) Regulation
Electrification & Mobility › China NEV Leaders Regulation
000625.CS · Regulation · Neutral Changan confirmed receiving CATARC's brake pedal material survey questionnaire, part of possible revisions to automotive pedal standards.
7489.HK · Regulation · Neutral Voyah executives posted photos of their brake pedals emphasizing high-strength metal materials after the Maextro V800 pedal fracture incident.
Dongfeng Peugeot Citroen Automobile (DPCA) · Regulation · Neutral Dongfeng Peugeot Citroen executives posted photos of their own brake pedals emphasizing high-strength metal materials amid the pedal standards scrutiny.
GAC Honda Automobile Co., Ltd. · Regulation · Neutral GAC Honda executives posted photos of their own brake pedals emphasizing high-strength metal materials amid the pedal standards scrutiny.
600418.CG · Regulation · Neutral Industry insider close to JAC says many models have long used non-metallic composite brake pedal brackets for lightweighting, amid a CATARC standards survey that could tighten rules.
Read original ↗
红星资本局·1dRead more →
China
China▲

Guosheng Zhike first-half revenue hits 738 million yuan, says it will revisit equity incentive plan at an appropriate time

Guosheng Zhike said at its 2026 interim results briefing that it will revisit the equity incentive plan at an appropriate time, taking into account operating conditions and the capital market environment. In the first half, the company achieved operating revenue of 738 million yuan, up 14.29 percent year on year; net profit attributable to the parent company was 93.579 million yuan, up 14.05 percent; and net profit attributable to the parent company excluding non-recurring items was 87.5839 million yuan, up 13.75 percent. The company said current orders are in good shape, with ample orders on hand, and it is steadily advancing and implementing its capacity expansion plan. Machine tool orders in the second half are also good, and domestic substitution demand for five-axis products in downstream sectors is improving. The company has developed customized solutions in six major industries: precision molds, wind power, civil aviation, semiconductors, humanoid robots, and new energy vehicles. Its machine tool products have been applied in volume at leading semiconductor customers and have also been adopted by humanoid robot-related customers. The company is steadily advancing in-house development of core functional components. Single swing heads, double swing heads, and offset swing heads for five-axis gantry machines continue to be applied in volume, and the self-sufficiency rate keeps rising, which is expected to create room for gross margin improvement over the medium to long term.
688558.CG · Capital · Positive H1 revenue rose 14.29% to 738 million yuan and net profit attributable to parent rose 14.05%, with plans to revisit an equity incentive plan.
688558.CG · Demand · Positive Company reports ample orders on hand, good second-half machine tool orders, and improving domestic substitution demand for five-axis products.
Read original ↗
读创财经·1dRead more →
China
China▼

Allist Responds to Failure of Furmonertinib Overseas Phase III Clinical Study

Allist responded to media on October 9 regarding the failure of the overseas Phase III clinical study of its core product furmonertinib, stating that the FURVENT study data require further analysis and that the company will determine subsequent development and regulatory communication plans. The company believes the FURVENT study results will not affect furmonertinib's sales in the third quarter or in the future, as current sales of the drug mainly come from the first-line treatment indication for EGFR-sensitive mutations. Allist said that at the subsequent global investigator meeting for the FURVENT study, experts believed furmonertinib met prior efficacy expectations for EGFR exon 20 insertion mutations; the chemotherapy arm's progression-free survival assessed by blinded independent central review differed substantially from investigator-assessed results, and apart from this difference, other data for furmonertinib performed well. On the same day, the National Healthcare Security Administration separately published the first batch of primary-level disease categories, including 31 DRG primary-level disease groups and 127 DIP primary-level disease categories, for local implementation reference.
About megatrends
Biotech & Genomic Medicine › Oncology Therapeutics Technology
688578.CG · Technology · Negative Overseas Phase III FURVENT study of core product furmonertinib failed, requiring further data analysis and uncertain regulatory path.
Read original ↗
21世纪经济·1dRead more →
China
China▲

Focus Media's acquisition of Xinchao Media equity approved with restrictive conditions in antitrust review

The elevator media industry consolidation that has drawn significant market attention has made important progress. On October 10, the State Administration for Market Regulation issued an announcement that, following a review in accordance with the law, it approved Focus Media's acquisition of Xinchao Media equity with restrictive conditions attached. Focus Media holds a market share of 50 to 55 percent in China's elevator media advertising market, while Xinchao Media holds 5 to 10 percent, giving the combined entity a total market share of 55 to 60 percent. Focus Media plans to issue shares and pay cash to purchase 90.02 percent of the target company's equity from 45 shareholders of Chengdu Xinchao Media Group, including Chongqing Jingdong Haijia E-commerce, Zhang Jixue, and Baidu Online Network Technology Beijing. The transaction consideration is 7.794 billion yuan, whereas in April 2025 the company had planned to acquire 100 percent of Xinchao Media for 8.3 billion yuan. Focus Media has committed that, without legitimate reasons, the combined entity's actual annual transaction prices in each city will not exceed the actual transaction prices of Focus Media and Xinchao Media in the corresponding cities during the 24 months before the effective date, and will waive all related rights arising from exclusive clauses already concluded and in effect with property companies and other holders of elevator media point resources, and will not enter into exclusive clauses or automatic renewal clauses when signing or renewing point agreements.
002027.CS · Regulation · Positive Antitrust regulator approved Focus Media's acquisition of Xinchao Media equity (with restrictive conditions), clearing the deal.
成都新潮传媒集团股份有限公司 (Chengdu Xinchao Media) · Regulation · Positive Antitrust approval clears the acquisition of 90.02% of Chengdu Xinchao Media's equity by Focus Media.
新潮传媒集团有限公司 · Regulation · Positive Regulator approved Focus Media's acquisition of Xinchao Media equity, advancing the target's sale.
Read original ↗
上海证券报·1dRead more →
China
China▲

KingMed Diagnostics Co-releases DeepGEM 2.0, a Multimodal AI Model for Lung Cancer Pathology Genomics

On October 10, the AI-Empowered Precision Diagnosis and Treatment of Lung Cancer Summit Forum and the launch ceremony for the National Respiratory Medicine Center's Lung Cancer Precision Diagnosis and Treatment Standardization Project, hosted by the National Respiratory Medicine Center of the First Affiliated Hospital of Guangzhou Medical University and the Guangdong Provincial Chest Disease Society, and organized by KingMed Diagnostics, was held in Guangzhou. At the event, DeepGEM 2.0, a multimodal AI model for lung cancer pathology genomics jointly developed by the First Affiliated Hospital of Guangzhou Medical University and KingMed Diagnostics, was officially released. A multicenter research project involving 50 medical institutions nationwide was also launched, marking the model's formal entry into large-scale clinical validation. According to Dr. Liu Si, head of KingMed Diagnostics' artificial intelligence division, DeepGEM 2.0 analyzes routine digital pathology slide images without requiring additional sampling and can deliver results in as little as one minute. Building on the original six genes—EGFR, KRAS, ALK, ROS1, TP53, and LRP1B—it adds BRAF, ERBB2, FGFR, MET, NTRK, and RET, bringing the total to 12 genes and achieving full coverage of genes corresponding to approved targeted therapies for lung cancer in China. The model will subsequently be deployed in a lightweight form at more than 500 medical institutions. Using an approach of AI-based initial screening combined with targeted validation of specific genes, it is expected to reduce the cost of lung cancer genetic testing to the range of several hundred yuan. Zhong Nanshan, an academician of the Chinese Academy of Engineering and director of the Guangzhou National Laboratory, said that in the new AI era, scientific research must aim high while serving the people. In 2025, the First Affiliated Hospital of Guangzhou Medical University, together with KingMed Diagnostics and Tencent, released DeepGEM, a multimodal pathology genomics model capable of identifying genes from images. After nearly a year of multicenter data validation and clinical refinement, and iterative optimization using nearly 8,000 digital pathology slides from 31 provinces across China provided by KingMed Diagnostics, it has been upgraded to version 2.0. Liang Yaoming, chairman and CEO of KingMed Diagnostics, said that AI pathology technology brings new opportunities to narrow regional disparities in diagnosis and treatment and to reduce costs while improving efficiency. KingMed Diagnostics will leverage the network advantages of its nationwide intelligent medical diagnostic service platform to bring innovative pathology AI technology to primary-level healthcare.
About megatrends
Biotech & Genomic Medicine › Diagnostics & Precision Testing ▲Technology
Biotech & Genomic Medicine › Tools, Diagnostics & CDMO ▲Technology
603882.CG · Technology · Positive KingMed co-released DeepGEM 2.0, a multimodal AI model for lung cancer pathology genomics, expanding to 12 genes and entering large-scale clinical validation.
Read original ↗
证券时报·1dRead more →
China
China

All-Solid-State Battery Concept Stocks Surge; CATL Turnover Exceeds 16 Billion Yuan; No Company Has Yet Provided a Mass-Production Timeline

The all-solid-state battery concept has once again been heatedly speculated by the market. The A-share battery sector rose against the trend amid a sluggish broader market. On October 9, CATL rose 3.84 percent, with turnover of 16.028 billion yuan and net main capital inflow of nearly 2.61 billion yuan. Tinci Materials, Farasis Energy, Great Power Energy and other stocks also moved higher during the same period. According to a review by China Times reporters, the solid-state battery progress of multiple battery and battery material companies is mostly still in the research and development or pilot stage, and large-scale mass production is still far off. At present, no company has put forward a mass-production timeline for all-solid-state batteries. Great Power Energy said there is currently no mass-production timeline, and it depends on upstream raw material prices. The raw materials are mainly solid electrolytes, and no production line has been built yet; it is only at the pilot stage. Tinci Materials said its solid-state battery electrolyte follows the sulfide route and is in the pilot stage, with one pilot production line put into use in the third quarter. Some industry insiders expect that mass production of all-solid-state batteries should occur no earlier than 2028 to 2030, and the current stage is equivalent to technical verification. On the policy front, seven departments including the Ministry of Industry and Information Technology jointly issued the 15th Five-Year Plan for the Development of the New Battery Industry, the first national-level special plan in China's battery field. It proposes that by 2030, all-solid-state batteries will initially achieve large-scale application, long-life lithium batteries will reach a cycle life of 15,000 times, and 19 tasks will be deployed around five major directions including full-chain innovation.
About megatrends
Electrification & Mobility › Next-gen Cells (Solid-state / Silicon-anode) ▲Technology
Electrification & Mobility › Battery Cells & Pack Manufacturing Technology
Electrification & Mobility › Battery Components & Materials ▲Technology
Electrification & Mobility › Incumbent Li-ion Cell Makers Technology
002709.CS · Technology · Neutral Its solid-state battery electrolyte (sulfide route) is in the pilot stage with one pilot line in use in Q3, but no mass-production timeline.
300438.CS · Technology · Neutral Says it has no mass-production timeline for all-solid-state batteries, is only at pilot stage, and depends on upstream raw material prices.
300750.CS · · Neutral Rose 3.84% with heavy turnover as part of the all-solid-state battery concept rally, with no company-specific development of its own.
Read original ↗
华夏时报网·1dRead more →
China
China▼

Over 70 computing power leasing concept stocks; regulators crack down on hype-chasing and cross-sector drift

Computing power leasing is becoming one of the most crowded tracks in the A-share market. According to data from the China Academy of Information and Communications Technology, the domestic computing power leasing market reached 68 billion yuan in the first quarter of 2026, up about 60 percent year on year, and is expected to exceed 260 billion yuan for the full year. During the same period, domestic AI computing power demand grew 417 percent year on year, while supply grew only 128 percent. According to a Securities Times report in June this year, there are already more than 70 computing power leasing concept stocks, spanning 15 industries, with market capitalizations ranging from 2 billion yuan to 120 billion yuan. A recent investigation by Cailian Press found that among 16 listed companies with computing power contracts exceeding 500 million yuan, 10 had contracts that were terminated after a period of disclosure or had still not begun performance. Among them, Lanyun Technology's 3.707 billion yuan computing power cloud service agreement had still not entered actual performance as of September 8, 2026, while Annil is expected to lose up to 60.4285 million yuan after the termination of its acquisition of a 22 percent stake in Shenzhen Innovation Technology Co., Ltd. Samples of main-business drift are also dense. Qunxing Toys announced the termination of its restructuring, which had lasted nearly eight months, on the evening of October 20. Lianhua Holdings recorded computing power service revenue of 122 million yuan in 2025, accounting for only 3.53 percent of its total operating revenue of 3.452 billion yuan, while the value of computing power leasing contracts terminated early in the same period reached 1.228 billion yuan. On the regulatory front, China Securities Regulatory Commission Chairman Wu Qing made a clear statement at the 2026 Lujiazui Forum, saying that the commission will strictly investigate and punish those who use technology as a pretext to chase hot topics and speculate on concepts. So far this year, the commission has investigated and dealt with seven cases of misleading statements. On July 6, the Shanghai Stock Exchange also upgraded the permission functions of its SSE e-interaction platform, suspending reply permissions for 12 months for companies penalized for hype-chasing.
About megatrends
Artificial Intelligence › AI Compute Cloud & Neoclouds ▼Regulation
Artificial Intelligence › AI Data Center & Build-out Regulation
Artificial Intelligence › Colocation & Hyperscale REITs Regulation
002575.CS · Capital · Negative Qunxing Toys announced termination of its nearly eight-month restructuring, a failed deal tied to the computing-power leasing hype
002875.CS · Capital · Negative Annil expects to lose up to 60.43 million yuan after terminating its acquisition of a 22% stake in Shenzhen Innovation Technology
Read original ↗
海报新闻·1dRead more →
China
China▲

Huate Gas's import-substitution products rise to 57, employee shareholding platform denies cashing out at highs

Huate Gas said at its 2026 semi-annual results briefing on October 8 that the number of products for which it has achieved import substitution has increased from 22 at the time of its IPO to 57, and that it will focus on commercializing high-end electronic specialty gases such as disilane, hydrogen bromide, and boron trichloride. In response to investor questions about continued share reductions by employee shareholding platforms and senior executives, the company said that the three entities, including Xiamen Huahong Duofu, are all pre-IPO employee shareholding platforms established in 2012, and that the reductions were driven by partners' capital planning needs. There was no cashing out at highs or lack of confidence in the company's development, and block trades with certain discounts were chosen to improve reduction efficiency and reduce the impact on the secondary market. The company said its sales pricing comprehensively considers factors such as product costs, market competition, and customers' gas consumption scale, stability, and credit periods, with pricing characterized by case-by-case negotiation. On the performance front, the 2026 semi-annual report published on August 25 showed operating revenue of 872 million yuan, up 28.95 percent year on year; net profit attributable to the parent company of 92.83 million yuan, up 19.16 percent; non-GAAP net profit attributable to the parent company of 89.94 million yuan, up 19.29 percent; and net operating cash flow of 133 million yuan, up 46.93 percent year on year. In the first half, specialty gas business revenue reached 586.04 million yuan, up 38.56 percent year on year, semiconductor segment revenue reached 342.89 million yuan, up 28.22 percent year on year, and helium and related products accounted for about 20 percent of total operating revenue, with revenue up 133 percent year on year.
About megatrends
Critical Materials & Supply Chain › Electronic & Specialty Gases ▲Technology
Critical Materials & Supply Chain › Electronic & Semiconductor Materials ▲Technology
Critical Materials & Supply Chain › Specialty Chemicals & Industrial Gases ▲Technology
Critical Materials & Supply Chain › Semiconductor Materials ▲Technology
688268.CG · Capital · Positive H1 2026 revenue rose 28.95% to 872 million yuan and net profit attributable to parent rose 19.16% to 92.83 million yuan.
688268.CG · Demand · Positive Import-substitution products rose from 22 at IPO to 57, with specialty gas and semiconductor segment revenue up 38.56% and 28.22% YoY, signaling growing end-customer adoption.
厦门华弘多福 · Capital · Neutral Xiamen Huahong Duofu, a pre-IPO employee shareholding platform, reduced its stake for partners' capital planning needs, which the company said was not cashing out at highs.
Read original ↗
读创财经·1dRead more →
LaosChinaMyanmar (Burma)United States
China

Laos Plans to Halt Raw Ore Exports by Mineral Type and Timeline, Stops Approving New Rare Earth Projects

Lao Minister of Industry and Commerce Malaythong Kommasith explained the shift in national mining development policy at the tenth session of the National Assembly. The draft of the new Prime Ministerial Decree on Improving Policies and Strengthening Management of Mineral Resource Development in the New Phase proposes four policy directions, including establishing ten criteria for selecting investors, requiring one hundred percent open and transparent bidding for projects, clearly planning to stop raw ore exports, and shifting management toward digitalization while implementing ESG standards. Among these, approvals for new rare earth projects will be halted absolutely. For already approved projects, the Ministry of Industry and Commerce will formulate a plan to reduce raw ore exports by the end of 2026 and submit it to the government for approval. For minor metals such as cobalt, tungsten, and nickel, raw ore exports will be fully stopped before 2030. Several industry analysts told Jiemian News that the new Lao policy will have limited impact on China's overall mineral supply and demand landscape. Li Congming, a rare earth industry analyst at Shanghai Ganglian, pointed out that China has a relatively high self-sufficiency rate for rare earth raw materials, and the scale of imports from Laos is not large compared with Myanmar and the United States. However, since 2025, as US import volumes have dropped sharply, the share of Lao ore has increased. Data from Antaike show that in 2025, China's imports of intermediate rare earth smelting products from Laos rose 57.8 percent year on year, with Lao ore accounting for 25 percent, surpassing the 19 percent share from the United States. Chen Qiqi, an antimony industry analyst at Shanghai Ganglian, said Laos accounts for only about 2 percent of China's total antimony raw material imports, and the figure was 2.81 percent from January to August this year. The disappearance of that import volume would actually reduce downward pressure on domestic prices in the short term, making its symbolic significance greater than its practical impact. Bai Qiong, a nickel industry analyst at Shanghai Ganglian, said Laos has cobalt reserves exceeding 100,000 tonnes and nickel resources of a certain scale, but its output accounts for an extremely low share globally. Tungsten industry analyst Lü Yannan said China's imports of tungsten concentrate from Laos account for less than 1 percent of total domestic tungsten raw material imports, so the impact is basically negligible. The new policy is the result of continued tightening of mining regulation in Laos in recent years. In May 2026, Directive No. 11 of the Central Committee of the Lao People's Revolutionary Party explicitly banned raw ore exports for the first time. In July, the Standing Committee of the special session of the tenth National Assembly proposed setting a two-to-three-year deadline to stop raw ore exports. The new Prime Ministerial Decree issued in October turns those principles into a concrete ban plan by mineral type and timeline.
About megatrends
Critical Materials & Supply Chain › Rare-Earth Mining & Oxide/Concentrate ▼Regulation
Critical Materials & Supply Chain › Rare Earths & Permanent Magnets Regulation
Critical Materials & Supply Chain › Nickel & Cobalt Mining ▼Regulation
Read original ↗
去向”实施严格核查·1dRead more →
China
China▲

Prebaked Anode Prices Rise for Second Consecutive Month, Hitting Three-Year High

Domestic prebaked anode prices have risen for the second consecutive month, reaching a near three-year high. A reporter from Cailian Press recently learned from the industry chain that a large electrolytic aluminum plant in Shandong raised its October 2026 prebaked anode procurement benchmark price by 400 yuan per tonne compared with September, implementing a cash price of 6,130 yuan per tonne. This marks the second consecutive monthly increase since the 100 yuan per tonne rise in August. Currently, prebaked anode market prices in the Shandong region have climbed to between 6,130 yuan and 6,430 yuan per tonne, up about 25 percent year on year, the highest since February 2023. The direct driver of this round of price increases is raw material costs. Coal tar pitch remains at elevated prices due to tight supply of high-temperature coal tar, while petroleum coke prices have also rebounded in some areas. Data from Longzhong Information shows that petroleum coke prices have risen from about 2,500 yuan per tonne at the start of the year to above 3,100 yuan per tonne by the end of September. Global downstream consumption continues to expand, and domestic demand in new energy sectors such as power batteries and energy storage remains strong, directly boosting domestic aluminum consumption and providing rigid support for prebaked anodes. As the world's leading commercial prebaked anode producer, Sunstone Development has 4.06 million tonnes of prebaked anode production capacity in operation in 2026, with an additional planned capacity of about 1.12 million tonnes under preparation. The company said that with cost control measures such as centralized petroleum coke procurement and intelligent blending, as well as scale advantages, its profit margin is expected to be further optimized.
603612.CG · Pricing · Positive Prebaked anode prices hit a three-year high on rising raw material costs, and Sunstone as the leading producer expects its profit margin to be further optimized via cost control and scale.
Read original ↗
China
China▼

Mingchen Health's acquisition of Kashgar Aoshu fails to meet performance commitment; original shareholders required to compensate 104 million yuan

Kashgar Aoshu Network Technology, a wholly owned subsidiary of Mingchen Health, has been hit with multiple new enforcement records, and its legal representative Dai Tenghui has also been listed as a person subject to enforcement and a dishonest debtor. In December 2022, Mingchen Health acquired 100% equity in Kashgar Aoshu from Xingao Technology with its own funds of 72.7 million yuan. However, Kashgar Aoshu posted a cumulative net loss of 31.4635 million yuan from 2023 to 2025, failing to meet the commitment made at the time of acquisition of a cumulative net profit of no less than 72.7 million yuan over three years. Under the agreement, the original shareholders are required to compensate 104 million yuan in cash. To date, the company has received 25 million yuan in compensation and says it is confident of recovering the full amount. Kashgar Aoshu's two games, "Zhenhun Street: Born to Be King" and "Realm: Blade Cry," both failed to achieve the expected results. As of the end of June 2026, its net assets stood at negative 107 million yuan. In the first half of this year, its operating revenue was 3.437 million yuan and its net loss was 3.6655 million yuan. In the first half of 2026, Mingchen Health achieved operating revenue of 896 million yuan, up 25.90% year on year, while its net loss was 5.0679 million yuan, down 112.34% year on year. Among this, online gaming revenue was 658 million yuan, accounting for 73.45% of total revenue.
002919.CS · Capital · Negative Acquisition of Kashgar Aoshu failed its performance commitment, triggering 104 million yuan compensation and a subsidiary with negative net assets.
喀什奥术网络科技有限公司 · Capital · Negative Kashgar Aoshu posted a cumulative net loss, missed its profit commitment, has negative net assets, and faces enforcement records.
广州星奥科技有限公司 · Capital · Neutral Xingao Technology was the original seller of Kashgar Aoshu and is among the original shareholders required to pay compensation, but no specific impact on it is detailed.
Read original ↗
中国经营网·1dRead more →
China
China▲impact 4

China Jushi Expects First Three Quarters Attributable Net Profit to Double Year-on-Year to 5.136 Billion to 5.393 Billion Yuan

China Jushi released a positive profit alert on October 9, expecting attributable net profit for the first three quarters of 2026 to reach 5.136 billion to 5.393 billion yuan, an increase of 2.568 billion to 2.825 billion yuan compared with the same period last year, up 100% to 110% year-on-year. The company also expects attributable net profit excluding non-recurring items to be 5.225 billion to 5.486 billion yuan, likewise up 100% to 110% year-on-year. The main reason for the expected profit growth is that demand in major downstream application areas for fiberglass increased in the first three quarters of 2026, with both product volume and prices rising. The company improved profitability by accelerating product structure optimization, strengthening technological innovation, and expanding market development. In the first half of this year, China Jushi already achieved revenue of 11.159 billion yuan, up 22.5% year-on-year, and attributable net profit of 2.933 billion yuan, up 73.9% year-on-year. In the secondary market, the stock rose from around 10 yuan to more than 77 yuan since last year, then entered a pullback. The latest price is 38.57 yuan, roughly halved from its high point in June this year.
600176.CG · Demand · Positive Fiberglass demand in major downstream applications increased, driving both volume and prices higher and doubling expected net profit.
Read original ↗
读创财经·1dRead more →
China
China▼impact 4

Jindike halts sales of core quadrivalent flu vaccine; full-year revenue may fall below 100 million yuan, triggering delisting risk warning

Jindike issued a risk warning announcement on the evening of October 9, saying that because the World Health Organization adjusted the recommended composition of influenza vaccines, the company will no longer sell its core product, the quadrivalent influenza vaccine, in this flu season. The newly approved trivalent influenza vaccine has no products available for sale yet, so full-year revenue may fall below 100 million yuan and the company may fail to return to profitability. If the annual report triggers the financial delisting risk warning condition, the Shanghai Stock Exchange will impose a delisting risk warning on the company's shares. According to the recommended composition for the 2026-2027 Northern Hemisphere influenza vaccines published by the World Health Organization and the Chinese National Influenza Center, the B/Yamagata lineage virus has been removed, and quadrivalent influenza vaccines containing that lineage no longer meet current seasonal vaccination demand, making trivalent influenza vaccines the main products promoted in the market. Jindike's operating revenue currently comes entirely from the quadrivalent influenza vaccine. The trivalent vaccine has just been approved and still needs to obtain a biological product batch release certificate before it can be marketed, and sales are also constrained by the progress of local government procurement and bidding. As of the announcement date, no trivalent vaccine is available for sale. The company listed on the STAR Market in 2021, with operating revenue of 318 million yuan in its first year of listing. Since then, performance has continued to deteriorate, with net profit negative for three consecutive years: a loss of 70.99 million yuan in 2023, a loss of 93.5 million yuan in 2024, and a loss widening to 178 million yuan in 2025. In the first half of 2026, revenue was 910,900 yuan, down 74.15 percent year on year, and net profit attributable to the parent company was negative 51.07 million yuan, with the loss widening 28.79 percent year on year. As of the close on October 9, Jindike traded at 19.17 yuan per share, up 5.21 percent, with a total market value of 2.362 billion yuan.
About megatrends
Biotech & Genomic Medicine › Vaccines (Recombinant & Traditional) ▼Demand
688670.CG · Regulation · Negative WHO composition change removed the B/Yamagata lineage, making Jindike's only revenue-generating quadrivalent flu vaccine unsellable and triggering a delisting risk warning.
Read original ↗
中国基金报·1dRead more →
China
China▼

Shaanxi BC&TV Network faces pre-restructuring application over 5.1133 million yuan debt; court accepts filing

Over a matured debt of 5.1133 million yuan, Shaanxi BC&TV Network has been hit with a pre-restructuring and restructuring application by creditor Xi'an Guanghua Communication Technology Co., Ltd., and the Xi'an Intermediate People's Court has decided to accept the pre-restructuring filing. The company announced on the evening of October 9 that it received a notice letter from the creditor on October 8, in which the creditor applied on the grounds that the company is unable to repay the matured debt of 5.1133 million yuan, clearly lacks solvency, but still retains restructuring value. On October 9, the company received a decision letter from the court, which appointed the liquidation group of Shaanxi BC&TV Network Media Group Co., Ltd. as the interim administrator for the pre-restructuring. The interim administrator simultaneously launched a public recruitment of restructuring investors. Interested investors must submit application materials and pay a registration deposit of 10 million yuan before 6 p.m. on November 8, 2026. Under equal conditions, priority will be given to those whose assets or businesses match the company's main business or the future 'technology plus' direction in related extended business areas, or who can provide industrial synergy or business resource support. Previously, on the evening of September 28, the company disclosed that as of the announcement date, cumulative overdue bank debt principal and interest amounted to 227 million yuan, accounting for 41.80 percent of the most recent audited net assets. The company's net profit attributable to the parent company recorded losses of 626 million yuan, 1.059 billion yuan, and 1.499 billion yuan respectively from 2023 to 2025, with a combined three-year loss of nearly 3.2 billion yuan. The 2026 half-year report shows first-half operating revenue of 529 million yuan, down 18.28 percent year on year, while net profit attributable to the parent company recorded a loss of 488 million yuan, widening from the 360 million yuan loss in the same period last year. Net assets attributable to shareholders of the listed company were only 54.48 million yuan, down nearly 90 percent from the end of the previous year.
600831.CG · Regulation · Negative Court accepted a pre-restructuring/restructuring filing over a 5.1133 million yuan matured debt, with an interim administrator appointed and restructuring investors being sought.
西安广华通信技术有限公司 · Regulation · Neutral Creditor Xi'an Guanghua Communication Technology filed the pre-restructuring application over the 5.1133 million yuan matured debt; outcome for the creditor is unclear.
Read original ↗
China
China▲

AI semiconductor sector enters earnings verification phase, Amlogic forecasts Q3 net profit growth of over 80%

The AI semiconductor sector has moved from a phase where any tangential connection drove gains into a period of separating substance from hype and verifying earnings. After hitting a record high of 7,808.44 points, the CS Artificial Intelligence Index pulled back sharply, with the maximum drawdown from its low of 5,261.89 points since July 1 reaching 32.61%. Wind data shows that as of October 8, the 50 constituent stocks had fallen an average of 7.45% for the year, with 34 of them down, accounting for 68%. Gains were concentrated in core computing power hardware segments: Accelink Technologies rose 117.31%, Sharetronic Data Technology rose 95.09%, and Montage Technology rose 67.56%, while H&T Intelligent Control fell 54.92%, Geovis Technology fell 49.17%, and Ecovacs Robotics fell 39.48%. The sector's average price-to-earnings ratio stood at 77.01 times, with 45 companies posting positive earnings and profitable companies accounting for 90% of the total. On the capital flow front, the net outflow of main funds has not changed, with net outflows of 21.294 billion yuan, 24.002 billion yuan, and 137.349 billion yuan over the past 5, 20, and 60 trading days respectively. As of October 8, the sector's first third-quarter earnings forecast was released, with Amlogic projecting revenue of 7.080 billion to 7.180 billion yuan and net profit of 1.260 billion to 1.310 billion yuan, representing a net profit increase of 80.58% to 87.74%.
About megatrends
Artificial Intelligence › AI Compute & Accelerator Silicon ▲Capital
688099.CG · Capital · Positive Amlogic released its first Q3 earnings forecast, projecting net profit growth of 80.58% to 87.74%.
Read original ↗
ChinaUnited States
China

China Warns Against AI Investment Overheating, Vows Accountability for Massive Losses in Party and State Council Development Guidelines

The Central Committee of the Communist Party of China and the State Council on the 9th issued development guidelines for high-tech industries including artificial intelligence. The guidelines explicitly state that if unplanned investment leads to major losses, those responsible will be held strictly accountable. While the move aims to accelerate industrial development amid the technology hegemony race with the United States, it also seeks to rein in an overheating initial public offering market. Amid growing international criticism over overproduction, the guidelines also call for correcting excessive domestic competition.
Jiji Press·1dRead more →
ChinaEuropean Union
China

China and EU Reach Understanding in Ministerial Talks on Electric Vehicle Exports

China's Ministry of Commerce said on the 9th that two days of talks in Beijing between Commerce Minister Wang Wentao and European Union Trade Commissioner Maros Sefcovic were "practical and constructive." It announced that the two sides reached an "understanding" on hybrid vehicle trade that is consistent with World Trade Organization rules. China and the EU agreed to continue discussions on review procedures and pricing matters related to the EU's investigation into Chinese electric vehicles, and made clear they will keep exploring tariff reductions for specific items within the framework of WTO rules, as well as continue dialogue on market access for medical devices. The EU's trade deficit with China has reached more than 1 billion euros per day. China and the EU have been at odds since 2024 over exports of cheap Chinese EVs; in the year from October 2025 to September 2026, EU imports of plug-in hybrid vehicles rose 86 percent while prices fell 20 percent, and China's share of PHEV import value in 2025 was about 30 percent, but more than half of imports are now made in China. The third round of regular consultations will be held in March 2027, and a ministerial-level video meeting is also scheduled for next January.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) Regulation
Electrification & Mobility › China NEV Leaders Regulation
Read original ↗
ロイター·1dRead more →
United StatesChina
Chinaimpact 4

Delta Falls 5% on Q3 Earnings Miss, Tesla Gains 3.6% on China Sales

Delta Air Lines shares fell about 5% in premarket trading after the carrier reported September-quarter adjusted earnings of $1.72 per share, missing the $1.82 consensus estimate, and lowered its full-year profit outlook to about $5.35 per share. Adjusted revenue rose 16% to $17.59 billion but came in slightly below expectations, with Delta citing elevated fuel costs that surged 62% to $4.14 billion in the quarter; the airline absorbed more than $500 million in additional fuel costs versus its early July guidance and expects $6 billion in higher fuel expenses for the full year. Tesla shares gained about 3.6% after China Passenger Car Association data showed deliveries of Model 3 and Model Y vehicles from its Shanghai factory rose 5% year-over-year to 95,366 units in September, extending its streak of annual sales gains to 11 consecutive months, while third-quarter shipments of Shanghai-built vehicles grew 13.7% even as global deliveries declined 2.1%. Apple shares fell about 2.6% in premarket trading on reports it cut component orders for some iPhone 18 Pro models after weaker-than-expected demand, and telecom stocks dropped sharply after SpaceX agreed to acquire a nationwide low-band spectrum license, with AT&T down 8%, Verizon Communications down 7.8%, and T-Mobile US down 7.6%, while SpaceX shares rose 4.3%. Ambarella shares rose 5.3% following reports that Qualcomm may be working with advisers on a possible deal to acquire the chip designer, speculation circulated via a Betaville alert that follows prior reports Ambarella is in advanced talks with potential buyers including NXP Semiconductors. Wall Street regained some momentum on Friday, with the S&P 500 up 0.4%, the Dow up 0.6%, and the Nasdaq Composite up 0.5%.
About megatrends
Electrification & Mobility › Passenger EV OEMs (BEV / PHEV) ▲Demand
Electrification & Mobility › Western / Legacy & Pure-play OEMs Demand
AAPL · Demand · Negative Apple cut component orders for some iPhone 18 Pro models after weaker-than-expected demand.
AMBA · Capital · Positive Ambarella rose on reports Qualcomm may be working with advisers on a possible acquisition of the chip designer.
DAL · Capital · Negative Delta missed Q3 earnings estimates and lowered its full-year profit outlook.
SPCX · Regulation · Positive SpaceX agreed to acquire a nationwide low-band spectrum license, a regulatory/spectrum asset deal that lifted its shares 4.3%.
T · Competition · Negative AT&T fell 8% after SpaceX agreed to acquire a nationwide low-band spectrum license, intensifying wireless competition.
TMUS · Competition · Negative T-Mobile US dropped 7.6% after SpaceX agreed to acquire a nationwide low-band spectrum license, a new competitive threat.
Read original ↗
Seeking Alpha·1dRead more →
China
China

China Eases Requirements for Launching Equity Mutual Funds, Lowering Minimum Raise from 200 Million Yuan to 50 Million Yuan

The China Securities Regulatory Commission published a draft rule on the 9th easing the requirements for launching equity mutual funds. Under the draft, the minimum amount that must be raised to launch an equity mutual fund would be lowered from the current 200 million yuan to 50 million yuan, or 7.47 million dollars. The easing would also apply to funds of funds that invest in other mutual funds, while requirements for bond-investing mutual funds would remain unchanged. In a statement, the CSRC said the rule revision is aimed at supporting the development of equity mutual funds and channeling more long-term capital into the stock market. The measure comes as China's main stock indexes approach their lowest levels in more than a year, with the CSI 300 index of major stocks closing on the 9th near a one-year low as selling in artificial intelligence supply chain-related shares intensified further.
ロイター·1dRead more →
ChinaUnited States
China

MINISO Mainland GMV Jumps 25%-30% in 26Q3 as YOYO IP Tops RMB1 Billion

MINISO Group reported that total GMV for its MINISO Chinese mainland business grew 25% to 30% year over year in the three months ended September 30, 2026, accelerating from the first half of 2026 on the back of high-single-digit same-store sales growth. During the National Day holidays from October 1 to October 7, 2026, MINISO Chinese mainland kept up its momentum with total GMV growth of 20% to 25% year over year, powered by low-single-digit SSSG. The company's flagship proprietary IP, YOYO, generated GMV of over RMB1 billion in the first nine months of 2026, entering the global IP One Billion Club, and has expanded into 53 countries and regions since its first product launch in June 2025. In overseas markets, MINISO USA posted GMV growth of around 20% year over year in 26Q3 and rebounded to over 30% GMV growth with positive SSSG in September 2026, helped by new product arrivals. Founder, Chairman and CEO Guofu Ye said YOYO has validated MINISO's strategic capability as a world-leading IP operation platform and that the company will empower more Chinese original IPs to scale up globally.
9896.HK · Demand · Positive MINISO Chinese mainland GMV grew 25%-30% YoY in 26Q3 with positive SSSG, and YOYO IP topped RMB1 billion GMV, signaling strong end-customer demand for its products.
Read original ↗
PR Newswire·1dRead more →
China
China

China Allocates 550 Billion Yuan in Unused Government Debt Quota to Local Governments

China's Ministry of Finance announced on the 9th that it has allocated 550 billion yuan, or 82 billion dollars, in unused government debt quota to support local government finances and expand infrastructure investment in pursuit of its growth target. Of that total, 300 billion yuan will go toward supporting the day-to-day operations of county-level governments, while the remainder will be directed to infrastructure projects, particularly those already under construction and those in economically strong regions. Policymakers have also tapped unused government debt quota as a year-end fiscal stimulus measure over the past two years, but this year's amount exceeds the totals for 2024 and 2025. In a separate statement, the ministry said it would implement a more proactive fiscal policy "vigorously and effectively" to support the expansion of domestic demand.
ロイター·1dRead more →
ChinaEuropean Union
China

China pushes back on EU, insists it is not weakening the yuan after surplus nears 1.2 trillion dollars

The People's Bank of China issued a statement rejecting accusations that China deliberately weakens the yuan to gain a trade advantage, after the European Union called on Beijing to let the currency strengthen in order to reduce a record-high trade surplus. The statement said China has no need or desire to weaken its currency to gain a competitive trade edge, and has never pursued devaluation to compete with other countries. It added that blaming another country's currency for a loss of competitiveness, which leads to weaker fiscal and monetary discipline and complex structural problems, amounts to shirking responsibility for necessary adjustment. The episode comes as Maros Sefcovic, the EU's trade chief, visits Beijing to discuss ways to narrow the bloc's trade deficit with China. In 2025, China posted a record trade surplus of nearly 1.2 trillion dollars, equal to roughly 6% of gross domestic product. The European Union, meanwhile, is concerned about its trade imbalance with China, which stood at 360.6 billion euros, or 404 billion dollars, in 2025, up 15% from a year earlier. The worry is that this could lead to a new China Shock 2.0, after another wave of Chinese exports floods into markets and rattles the industries and economies of trading partners. Earlier, in June, European Central Bank President Christine Lagarde urged world leaders to discuss the yuan being undervalued, which she cited as one factor behind imbalances and a risk to the global economy.
USDCNY.FOREX · Monetary · Positive China rejects EU/ECB pressure to let the yuan strengthen, signaling it will keep the currency weak/undervalued, which weakens CNY versus USD.
Read original ↗
Reuters·1dRead more →